tykhr
sign in
free sign up
Aytu BioScience Inc
Drug Manufacturers - Specialty & Generic
Healthcare
AYTU
9.10 M shares
NASDAQ US
traded
21 Feb 2025
listed
no
open
1.45
52 week high
3.36
high
1.45
52 week low
1.34
low
1.34
growth
-52.96 %
previous Close
1.38
P/E ratio
market cap
8.49 M
div yield
0
usd
Sep 2024
qoq
revenue
16.57 M
-7.80 %
net incoming
1.47 M
131.93 %
eps
0.00 %
81.71 %
eps surprise
55.88 %
net profit margin
8.89 %
34.00 %
operating incoming
-930.00 K
74.52 %
net change in cash
102 K
-58.54 %
cash on hand
20.11 M
0.51 %
cost of revenue
4.59 M
-24.40 %
top